The role of the PD-1 pathway in autoimmunity and peripheral tolerance
- PMID: 21276005
- DOI: 10.1111/j.1749-6632.2010.05919.x
The role of the PD-1 pathway in autoimmunity and peripheral tolerance
Abstract
Programmed death-1 (PD-1) is a surface receptor critical for the regulation of T cell function during immunity and tolerance. PD-1 interactions with its ligands PD-L1 and PD-L2 inhibit T cell effector functions in an antigen-specific manner. This paper examines the role of PD-1 in limiting autoreactivity and establishing self-tolerance and discusses the hypothesis that PD-1 ligand (PD-L) expression both spatially and temporally dictates the fate of self-reactive T cells during the breakdown of peripheral tolerance and development of autoimmunity. We focus our discussion on the role of PD-1/PD-L interactions during peripheral tolerance, the differential role for PD-L1 and PD-L2 in response to environmental or self-antigens, and the impact of PD-1 signaling on dynamic T cell motility and the T cell receptor (TCR) stop signal. Finally, we discuss the potential to selectively target the PD-1 pathway therapeutically to alter T cell function during autoimmunity.
© 2011 New York Academy of Sciences.
Similar articles
-
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.Immunol Rev. 2008 Aug;224:166-82. doi: 10.1111/j.1600-065X.2008.00662.x. Immunol Rev. 2008. PMID: 18759926 Review.
-
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.Nat Immunol. 2001 Mar;2(3):261-8. doi: 10.1038/85330. Nat Immunol. 2001. PMID: 11224527
-
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.Nat Immunol. 2007 Mar;8(3):239-45. doi: 10.1038/ni1443. Nat Immunol. 2007. PMID: 17304234 Review.
-
Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.Transplantation. 2007 Mar 27;83(6):774-82. doi: 10.1097/01.tp.0000256293.90270.e8. Transplantation. 2007. PMID: 17414712
-
Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.J Immunol. 2010 Dec 1;185(11):6563-71. doi: 10.4049/jimmunol.0903401. Epub 2010 Nov 1. J Immunol. 2010. PMID: 21041733
Cited by
-
Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.J Immunol. 2015 Apr 15;194(8):3551-3555. doi: 10.4049/jimmunol.1402262. Epub 2015 Mar 13. J Immunol. 2015. PMID: 25769925 Free PMC article.
-
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.Sci Transl Med. 2015 Mar 18;7(279):279ra41. doi: 10.1126/scitranslmed.aaa4691. Sci Transl Med. 2015. PMID: 25787767 Free PMC article.
-
Overcoming T cell exhaustion in infection and cancer.Trends Immunol. 2015 Apr;36(4):265-76. doi: 10.1016/j.it.2015.02.008. Epub 2015 Mar 18. Trends Immunol. 2015. PMID: 25797516 Free PMC article. Review.
-
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.Cancers (Basel). 2022 Jun 12;14(12):2898. doi: 10.3390/cancers14122898. Cancers (Basel). 2022. PMID: 35740564 Free PMC article.
-
Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4.Biochem Biophys Rep. 2018 Feb 6;13:123-128. doi: 10.1016/j.bbrep.2018.01.009. eCollection 2018 Mar. Biochem Biophys Rep. 2018. PMID: 29556567 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
